In an American Arbitration Association (AAA) dispute over early-stage drug candidates in a development agreement between two biopharmaceutical companies, CRA consultants quantified damages associated with the alleged breach of the agreement. Dr. Gregory K. Bell submitted an expert report quantifying actual loss damages and unjust enrichment and provided deposition and hearing testimony to support the damages assessment.
Richard Bergin joins CRA's Finance Practice as Vice President
CRA is pleased to announce that Richard Bergin has joined the company’s Finance Practice as a vice president. “We are very pleased to welcome Richard to CRA,”...